Motion control and electronic systems manufacturer Helios Technologies (NYSE: HLIO) will be announcing earnings results this Monday after market hours. Here’s what you need to know.
Helios beat analysts’ revenue expectations last quarter, reporting revenues of $220.3 million, up 13.3% year on year. It was a very strong quarter for the company, with an impressive beat of analysts’ organic revenue estimates and an impressive beat of analysts’ adjusted operating income estimates.
Is Helios a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, the market is expecting Helios’s revenue to grow 10.3% year on year, a reversal from the 7.2% decrease it recorded in the same quarter last year.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Helios rarely misses Wall Street’s revenue estimates.
Looking at Helios’s peers in the gas and liquid handling segment, some have already reported their Q4 results, giving us a hint as to what we can expect. Atmus Filtration Technologies delivered year-on-year revenue growth of 9.8%, beating analysts’ expectations by 5.5%, and Gorman-Rupp reported revenues up 2.4%, in line with consensus estimates. Atmus Filtration Technologies traded up 3.2% following the results while Gorman-Rupp was also up 10.7%.
Read our full analysis of Atmus Filtration Technologies’s results here and Gorman-Rupp’s results here.
There has been positive sentiment among investors in the gas and liquid handling segment, with share prices up 5.4% on average over the last month. Helios is up 10.2% during the same time and is heading into earnings with an average analyst price target of $70.83 (compared to the current share price of $71.39).
P.S. STOP buying the AI stocks everyone's talking about. The real money? It’s in the profitable pick nobody’s watching yet. We’ve identified an AI profit machine that’s flying under Wall Street’s radar—for now. We can’t keep this research public forever—grab your FREE copy before we pull it offline. GO HERE NOW.
